ISMP was shocked and saddened to learn that, once again, 1-4 a frontline healthcare practitioner has found herself on the receiving end of a criminal indictment after making a medication error that led to the tragic death of a patient. RaDonda Vaught, a 35-year-old registered nurse, was indicted on...
Resource Library
Whether you have experienced a medication error in your organization or you are proactively implementing prevention strategies, you are not alone. Thousands of organizations worldwide have relied on ISMP's resources for institutional change to reduce errors on a daily basis. These resources are developed from ISMP's review of reports through its national error reporting programs, peer-reviewed articles in its publications, and/or consensus gathering summits on topics pertinent to specific errors or hazards. ISMP offers a wide range of downloadable and easy to use resources. Many are free.
All Resources
The US Food and Drug Administration (FDA) approved LUMOXITI (moxetumomab pasudotox-tdfk) injection in September 2018. Lumoxiti is a CD22-directed cytotoxin indicated for the treatment of adult patients with relapsed or refractory hairy cell leukemia who received at least two prior systemic therapies...
In academic teaching hospitals, medical residents typically enter most of the medication orders for patients using electronic prescribing (e-prescribing) systems. However, little is known about the association between the residents’ level of training and the frequency of medication prescribing...
Problem: National news recently exposed details about a 2017 fatal medication error that happened at a large, prestigious hospital after the Centers for Medicare & Medicaid Services (CMS) briefly placed its Medicare reimbursement status in jeopardy. The hospital’s status was quickly restored...
In the latest issue of ISMP’s Quarter Watch™ , we examine the adverse drug events reported to the US Food and Drug Administration (FDA) Adverse Event Reporting System (FAERS) for 97 new drugs and biological products approved between 2015 and 2017, including: evolocumab ( REPATHA ) and alirocumab (...
Introduction One in every 1,000 medication orders in a hospital, and one in every 1,000 prescriptions in a pharmacy, have been associated with selecting the wrong drug while prescribing, transcribing, dispensing, or administering medications. 1-4 Drug name similarities are a primary cause of these...
Problem: In our November 1, 2018 newsletter, we shared the findings from a recent 2018 ISMP survey of 977 practitioners (mostly nurses) on adult intravenous (IV) push medication practices and compared these results to related ISMP surveys conducted between 2010 and 2014. The 2018 survey revealed...
ISMP has launched a new tool to help healthcare facilities identify and manage targeted risks associated with the use of IV push medications in adults. The ISMP Gap Analysis Tool (GAT) for Safe IV Push Medication Practices is designed to assist practitioners in evaluating their practices,...
In July and August 2018, we invited practitioners who administer intravenous (IV) push medications to adults to participate in a survey. 1 The survey was conducted in response to three prior ISMP surveys that revealed numerous risky practices associated with the administration of IV push medications...